Article ; Online: Plain
Magnetic resonance in chemistry : MRC
2021 Volume 59, Issue 7, Page(s) 746–751
Abstract: Favipiravir is an established antiviral that is currently being assessed as an investigational drug for the treatment of COVID-19. Favipiravir is strikingly similar to two molecules that the World Health Organization (WHO) lists as essential medicines, ... ...
Abstract | Favipiravir is an established antiviral that is currently being assessed as an investigational drug for the treatment of COVID-19. Favipiravir is strikingly similar to two molecules that the World Health Organization (WHO) lists as essential medicines, which also consist of a six-membered aromatic N-heterocycle bearing a carboxamide function: the anti-tuberculosis agent, pyrazinamide, and nicotinamide, also known as vitamin B |
---|---|
MeSH term(s) | Amides/analysis ; Amides/chemistry ; Antiviral Agents/analysis ; Antiviral Agents/chemistry ; Drug Contamination/prevention & control ; Niacinamide/analysis ; Niacinamide/chemistry ; Proton Magnetic Resonance Spectroscopy ; Pyrazinamide/analysis ; Pyrazinamide/chemistry ; Pyrazines/analysis ; Pyrazines/chemistry ; Quality Control ; World Health Organization |
Chemical Substances | Amides ; Antiviral Agents ; Pyrazines ; Niacinamide (25X51I8RD4) ; Pyrazinamide (2KNI5N06TI) ; favipiravir (EW5GL2X7E0) |
Language | English |
Publishing date | 2021-04-13 |
Publishing country | England |
Document type | Letter |
ZDB-ID | 1475029-6 |
ISSN | 1097-458X ; 0749-1581 |
ISSN (online) | 1097-458X |
ISSN | 0749-1581 |
DOI | 10.1002/mrc.5154 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.